SEP-363856 hydrochloride
Cat. No.：YN320765
| 产品名称: | SEP-363856 hydrochloride |
| CAS No.: | 1310422-41-3 |
| Chemical Name: | 4,7-dihydro-N-methyl-5H-thieno[2,3-c]pyran-7-methanamine, monohydrochloride |
| Synonyms: | SEP-856 hydrochloride |
| 分子量: | 219.73 |
| 分子式: | C₉H₁₄ClNOS |
| SMILES: | CNC[C@H]1C2=C(C=CS2)CCO1.Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | SEP-363856 (SEP-856) hydrochloride 是具有口服活性的、中枢神经系统活性的抗精神病活性化合物，具有研究精神分裂症的潜力。 |
| IC50和靶点: | [{name:"TAAR1:0.140 μM (EC50)"},{name: "5-HT1A Receptor:2.3 μM (EC50)"},{name: "5-HT1B Receptor:15.6 μM (EC50)"},{name: "5-HT1D Receptor:0.262 μM (EC50)"},{name: "5-HT2A Receptor:>10 μM (EC50)"},{name: "5-HT2C Receptor:30 μM (EC50)"},{name: "5-HT7 Receptor:6.7 μM (EC50)"}] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Dedic, N., Jones, P.G., Hopkins, S.C., et al.SEP-363856, a novel psychotropic agent with a unique, non-D2 receptor mechanism of actionJ. Pharmacol. Exp. Ther.371(1),1-14(2019)
